Enhanced Resistance to Tamoxifen by the c-ABL Proto-oncogene in Breast Cancer
Huajun Zhao(Wenzhou University), Shao‐Chun Wang(Asia University), Shuk‐Mei Ho(University of Arkansas for Medical Sciences), I‐Fen Chen(I-Shou University), Susan E. Waltz(Veterans Health Administration), Rina Plattner(University of Kentucky), Shyng‐Shiou F. Yuan(Kaohsiung Medical University), Yi‐Chen Lee(Kaohsiung Medical University), Hsueh-Ling Chang(I-Shou University), Ming‐Feng Hou(Kaohsiung Medical University Chung-Ho Memorial Hospital), Fu Ou‐Yang(Breast Center), Jonathan T. Sims(University of Kentucky)
Cited by 40
Related Papers
Chapel Hill bisphenol A expert panel consensus statement: Integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure
|Reproductive Toxicology|2007|711
c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF
|Genes & Development|1999|426
Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A
|Environmental Health Perspectives|2008|306
Dynamic Regulation of Estrogen Receptor-β Expression by DNA Methylation During Prostate Cancer Development and Metastasis
|American Journal Of Pathology|2004|202
Activation of Abl Tyrosine Kinases Promotes Invasion of Aggressive Breast Cancer Cells
|Cancer Research|2006|199